Literature DB >> 17005721

piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells.

Sareina Chiung-Yuan Wu1, Yaa-Jyuhn James Meir, Craig J Coates, Alfred M Handler, Pawel Pelczar, Stefan Moisyadi, Joseph M Kaminski.   

Abstract

A nonviral vector for highly efficient site-specific integration would be desirable for many applications in transgenesis, including gene therapy. In this study we directly compared the genomic integration efficiencies of piggyBac, hyperactive Sleeping Beauty (SB11), Tol2, and Mos1 in four mammalian cell lines. piggyBac demonstrated significantly higher transposition activity in all cell lines whereas Mos1 had no activity. Furthermore, piggyBac transposase coupled to the GAL4 DNA-binding domain retains transposition activity whereas similarly manipulated gene products of Tol2 and SB11 were inactive. The high transposition activity of piggyBac and the flexibility for molecular modification of its transposase suggest the possibility of using it routinely for mammalian transgenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005721      PMCID: PMC1622771          DOI: 10.1073/pnas.0606979103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Gene therapy on trial.

Authors:  E Marshall
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

2.  Development of hyperactive sleeping beauty transposon vectors by mutational analysis.

Authors:  Hatem Zayed; Zsuzsanna Izsvák; Oliver Walisko; Zoltán Ivics
Journal:  Mol Ther       Date:  2004-02       Impact factor: 11.454

3.  Chimeric Mos1 and piggyBac transposases result in site-directed integration.

Authors:  K J Maragathavally; J M Kaminski; C J Coates
Journal:  FASEB J       Date:  2006-07-28       Impact factor: 5.191

4.  Assay for movement of Lepidopteran transposon IFP2 in insect cells using a baculovirus genome as a target DNA.

Authors:  M J Fraser; L Cary; K Boonvisudhi; H G Wang
Journal:  Virology       Date:  1995-08-20       Impact factor: 3.616

5.  Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera.

Authors:  M J Fraser; T Ciszczon; T Elick; C Bauser
Journal:  Insect Mol Biol       Date:  1996-05       Impact factor: 3.585

6.  Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells.

Authors:  Z Ivics; P B Hackett; R H Plasterk; Z Izsvák
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

7.  Autoregulation of mariner transposase activity by overproduction and dominant-negative complementation.

Authors:  A R Lohe; D L Hartl
Journal:  Mol Biol Evol       Date:  1996-04       Impact factor: 16.240

8.  Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse.

Authors:  Lara S Collier; Corey M Carlson; Shruthi Ravimohan; Adam J Dupuy; David A Largaespada
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

9.  The Frog Prince: a reconstructed transposon from Rana pipiens with high transpositional activity in vertebrate cells.

Authors:  Csaba Miskey; Zsuzsanna Izsvák; Ronald H Plasterk; Zoltán Ivics
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

10.  Design of a nonviral vector for site-selective, efficient integration into the human genome.

Authors:  Joseph M Kaminski; Mark R Huber; James B Summers; Matthew B Ward
Journal:  FASEB J       Date:  2002-08       Impact factor: 5.191

View more
  168 in total

1.  "Calling cards" for DNA-binding proteins in mammalian cells.

Authors:  Haoyi Wang; David Mayhew; Xuhua Chen; Mark Johnston; Robi David Mitra
Journal:  Genetics       Date:  2012-01-03       Impact factor: 4.562

2.  Methods of cell purification: a critical juncture for laboratory research and translational science.

Authors:  Peter J Amos; Esra Cagavi Bozkulak; Yibing Qyang
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

3.  Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects.

Authors:  Johann Urschitz; Miyuri Kawasumi; Jesse Owens; Kazuto Morozumi; Hideaki Yamashiro; Ilko Stoytchev; Joel Marh; James A Dee; Kris Kawamoto; Craig J Coates; Joseph M Kaminski; Pawel Pelczar; Ryuzo Yanagimachi; Stefan Moisyadi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

4.  Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells.

Authors:  Xin Huang; Hongfeng Guo; Syam Tammana; Yong-Chul Jung; Emil Mellgren; Preetinder Bassi; Qing Cao; Zheng Jin Tu; Yeong C Kim; Stephen C Ekker; Xiaolin Wu; San Ming Wang; Xianzheng Zhou
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

Review 5.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

6.  Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease.

Authors:  Christian M Brommel; Ashley L Cooney; Patrick L Sinn
Journal:  Hum Gene Ther       Date:  2020-08-21       Impact factor: 5.695

7.  Self-Reporting Transposons Enable Simultaneous Readout of Gene Expression and Transcription Factor Binding in Single Cells.

Authors:  Arnav Moudgil; Michael N Wilkinson; Xuhua Chen; June He; Alexander J Cammack; Michael J Vasek; Tomás Lagunas; Zongtai Qi; Matthew A Lalli; Chuner Guo; Samantha A Morris; Joseph D Dougherty; Robi D Mitra
Journal:  Cell       Date:  2020-07-24       Impact factor: 41.582

8.  The piggyBac transposon holds promise for human gene therapy.

Authors:  Cédric Feschotte
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

9.  SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection.

Authors:  Yang Liu; Jennifer A Bartlett; Marissa E Di; Jennifer M Bomberger; Yvonne R Chan; Lokesh Gakhar; Rama K Mallampalli; Paul B McCray; Y Peter Di
Journal:  Am J Pathol       Date:  2013-03-15       Impact factor: 4.307

10.  piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.

Authors:  Pallavi V Raja Manuri; Matthew H Wilson; Sourindra N Maiti; Tiejuan Mi; Harjeet Singh; Simon Olivares; Margaret J Dawson; Helen Huls; Dean A Lee; Pulivarthi H Rao; Joseph M Kaminski; Yozo Nakazawa; Stephen Gottschalk; Partow Kebriaei; Elizabeth J Shpall; Richard E Champlin; Laurence J N Cooper
Journal:  Hum Gene Ther       Date:  2010-04       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.